{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T22:12:46Z","timestamp":1783807966811,"version":"3.55.0"},"reference-count":43,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2022,1,6]],"date-time":"2022-01-06T00:00:00Z","timestamp":1641427200000},"content-version":"vor","delay-in-days":5,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J Deutsche Derma Gesell"],"published-print":{"date-parts":[[2022,1]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Although rare, psychocutaneous disorders induced by prescription stimulants have been reported throughout the literature. A systematic review was conducted to identify all case reports and case series of prescription stimulant\u2010induced trichotillomania, tactile hallucinations, and delusional infestation. A total of 22 case reports were identified and relevant information was analyzed. Patients presenting with trichotillomania and tactile hallucinations induced by prescription stimulants were typically pediatric male patients being treated for attention deficit hypersensitivity disorder. Symptoms resolved after discontinuation of the offending medication. Patients presenting with delusional infestation secondary to stimulant use or abuse were typically adults who were misusing or abusing stimulant medication. Although symptoms typically improved or resolved after decreasing or discontinuing medication, several patients required the use of antipsychotic medication. While the observational nature of case reports and small number of patients limits meaningful analysis of trends and comparison, this study demonstrates that physicians, especially dermatologists and psychiatrists, should be aware of the potential for prescription stimulants to precipitate adverse psychocutaneous disorders in a minority of individuals.<\/jats:p>","DOI":"10.1111\/ddg.14669","type":"journal-article","created":{"date-parts":[[2022,1,6]],"date-time":"2022-01-06T13:44:00Z","timestamp":1641476640000},"page":"7-15","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Adverse psychocutaneous effects of prescription stimulant use and abuse: A systematic review"],"prefix":"10.1111","volume":"20","author":[{"given":"Cameron R.","family":"Moattari","sequence":"first","affiliation":[{"name":"State University of New York Downstate Health Sciences University College of Medicine  Brooklyn New York USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katlein","family":"Fran\u00e7a","sequence":"additional","affiliation":[{"name":"Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery Department of Psychiatry and Behavioral Sciences Institute for Bioethics and Health Policy University of Miami Miller School of Medicine  Miami FL USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2022,1,6]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2011.11030387"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0206100"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2018.17091048"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1037\/pha0000093"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.1997.68052032.x"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2010.05906.x"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2011.10.007"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/syn.20235"},{"key":"e_1_2_7_10_1","unstructured":"Adderall\u00ae Drug Label: FDA; Available from:https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2017\/011522s043lbl.pdf. [Last accessed: October 12 2021]."},{"key":"e_1_2_7_11_1","unstructured":"Ritalin\u00ae Drug Label: FDA; Available from:https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2013\/010187s077lbl.pdf. [Last accessed: October 12 2021]."},{"key":"e_1_2_7_12_1","unstructured":"Vyvanse\u00ae Drug Label: FDA; Available from:https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2017\/208510lbl.pdf. [Last accessed: October 12 2021]."},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1813751"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2021.04.033"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b2535"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1981.154"},{"key":"e_1_2_7_17_1","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM\u20105\u00ae) American Psychiatric Pub 2013.","DOI":"10.1176\/appi.books.9780890425596"},{"issue":"7","key":"e_1_2_7_18_1","first-page":"13","article-title":"Adderall\u2010induced trichotillomania: A case report","volume":"10","author":"Narine C","year":"2013","journal-title":"Innov Clin Neurosci"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1080\/08897070903442723"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000000719"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2017.0001"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004583-199804000-00009"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000001260"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00018-09"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2013.0144"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000134656.93147.F1"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e31818ce752"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004703-198106000-00003"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1177\/0883073808331357"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-3093"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1177\/0004867414525849"},{"key":"e_1_2_7_32_1","article-title":"Delusional parasitosis in a female treated with mixed amphetamine salts: a case report and literature review","volume":"2012","author":"Buscarino M","year":"2012","journal-title":"Case Rep Psychiatry"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcpc1305989"},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.1097\/CHI.0b013e318067fd7c"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.psym.2014.03.004"},{"issue":"10","key":"e_1_2_7_36_1","first-page":"415","article-title":"Estimated lifetime prevalence of trichotillomania in college students","volume":"52","author":"Christenson GA","year":"1991","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_7_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/0165-1781(90)90151-T"},{"key":"e_1_2_7_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2013.05.012"},{"key":"e_1_2_7_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/ppc.12246"},{"key":"e_1_2_7_40_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-016-0219-z"},{"key":"e_1_2_7_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2017.06.024"},{"key":"e_1_2_7_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mehy.2006.07.061"},{"key":"e_1_2_7_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2008.09.014"},{"key":"e_1_2_7_44_1","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1111\/ddg.14328","article-title":"Skin and psychosomatics \u2013 psychodermatology today","volume":"18","author":"Gieler U","year":"2020","journal-title":"J Dtsch Dermatol Ges"}],"container-title":["JDDG: Journal der Deutschen Dermatologischen Gesellschaft"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ddg.14669","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/ddg.14669","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ddg.14669","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,27]],"date-time":"2023-08-27T02:19:09Z","timestamp":1693102749000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ddg.14669"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["10.1111\/ddg.14669"],"URL":"https:\/\/doi.org\/10.1111\/ddg.14669","archive":["Portico"],"relation":{},"ISSN":["1610-0379","1610-0387"],"issn-type":[{"value":"1610-0379","type":"print"},{"value":"1610-0387","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"2021-07-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-10-10","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-01-06","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}